Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Santiago Perez‐Lloret, Daniel P. Cardinali
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Circadian disruption and human health
Anna Fishbein, Kristen L. Knutson, Phyllis C. Zee
Journal of Clinical Investigation (2021) Vol. 131, Iss. 19
Open Access | Times Cited: 232
Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin
Jana Tchekalarova, Rumiana Tzoneva
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3022-3022
Open Access | Times Cited: 54
The role of oxidative stress in intervertebral disc degeneration: Mechanisms and therapeutic implications
Xiang‐Long Chen, Anran Zhang, Kangcheng Zhao, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102323-102323
Open Access | Times Cited: 25
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Jeremy Hunt, Elizabeth J. Coulson, Rajendram V. Rajnarayanan, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 63
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Virna Margarita Martín Giménez, Natalia de las Heras, Vicente Lahera, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 41
Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm
Russel J. Reıter, Ramaswamy Sharma, Maira Smaniotto Cucielo, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 4
Closed Access | Times Cited: 28
Eat, sleep, repeat – endocrine regulation of behavioural circadian rhythms
Sarah Koop, Henrik Oster
FEBS Journal (2021) Vol. 289, Iss. 21, pp. 6543-6558
Open Access | Times Cited: 35
Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health
Russel J. Reıter, Ramaswamy Sharma, Sergio Rosales‐Corral, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 605, pp. 70-81
Closed Access | Times Cited: 25
Melatonin: Potential avenue for treating iron overload disorders
Jiancheng Yang, Qinghua Tang, Yuhong Zeng
Ageing Research Reviews (2022) Vol. 81, pp. 101717-101717
Closed Access | Times Cited: 23
Circadian rhythm alterations affecting the pathology of neurodegenerative diseases
Jaquelini Betta Canever, Letícia Yoshitome Queiroz, Ericks Sousa Soares, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 8, pp. 1475-1489
Open Access | Times Cited: 14
Alteration of circadian sleep-wake rhythm and salivary melatonin secretion in idiopathic/isolated REM sleep behavior disorder: Preliminary evidence
Matteo Carpi, Mariana Fernandes, Irene Risino, et al.
Sleep Medicine (2024) Vol. 119, pp. 135-138
Closed Access | Times Cited: 5
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
Michele Salemi, Giovanna Marchese, Giuseppe Lanza, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 712-712
Open Access | Times Cited: 21
Paraquat disrupts KIF5A-mediated axonal mitochondrial transport in midbrain neurons and its antagonism by melatonin
Huihui Hong, Jingdian Li, Tong Tong, et al.
The Science of The Total Environment (2024) Vol. 934, pp. 173119-173119
Closed Access | Times Cited: 4
Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting—A Comprehensive Review of Its Unusual Health Benefits
Lucas Fornari Laurindo, Otávio Augusto Garcia Simili, Adriano Cressoni Araújo, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 143-143
Open Access
Associations of physical activity, sedentary behavior, and sleep with risk of incident Parkinson’s disease: A prospective cohort study of 401,697 participants
Haishan Jiao, Shu‐Yi Huang, Wei Cheng, et al.
Chinese Medical Journal (2025)
Open Access
A Meta-Analysis of Melatonin Effects on Behavior of Rats Kept in Standard Conditions
N. V. Kuzmenko, В. А. Цырлин, М. Г. Плисс, et al.
Journal of Evolutionary Biochemistry and Physiology (2025) Vol. 61, Iss. 1, pp. 74-95
Closed Access
Melatonin and Inflammatory and Immune-Modulated Diseases: New Applications of a Metabolite Also Produced by Plants
Lucas Fornari Laurindo, Bárbara de Oliveira Zanuso, Élen Landgraf Guiguer, et al.
Reference series in phytochemistry (2025), pp. 103-128
Closed Access
Association of circadian rhythms with brain disorder incidents: a prospective cohort study of 72242 participants
Si‐Jia Chen, Yue‐Ting Deng, Yuzhu Li, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Nature and Science of Sleep (2022) Vol. Volume 14, pp. 1843-1855
Open Access | Times Cited: 16
Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer’s Disease
Mayuri Shukla, Bruno Vincent
Current Neuropharmacology (2023) Vol. 21, Iss. 5, pp. 1273-1298
Open Access | Times Cited: 7
Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder
Daniel P. Cardinali, A. Garay
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 797-797
Open Access | Times Cited: 7
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
Pablo Duarte, Patrycja Michalska, Enrique Crisman, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 11
Effect of melatonin on insomnia and daytime sleepiness, in patients with obstructive sleep apnea and insomnia (COMISA): A randomized double-blinded placebo-controlled trial
Tahereh Madani Motlaq, Besharat Rahimi, Shahideh Amini
Journal of Pharmaceutical Health Care and Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Molecularly Imprinted Electrochemical Sensor Based on CuxO/MXene Nanocomposite for Sensing of Melatonin
Xinyu Wang, Wenbin Wang, Meng Gao, et al.
ACS Applied Nano Materials (2024)
Closed Access | Times Cited: 2
Melatonin Increases Life Span, Restores the Locomotor Activity, and Reduces Lipid Peroxidation (LPO) in Transgenic Knockdown Parkin Drosophila melanogaster Exposed to Paraquat or Paraquat/Iron
Hector Flavio Ortega‐Arellano, Marlene Jiménez-Del-Río, Carlos Velez‐Pardo
Neurotoxicity Research (2021) Vol. 39, Iss. 5, pp. 1551-1563
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top